HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/2/G491    most recent 00452.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Blanco, P. G. Articles by Freedman, S. D. Search for Related Content PubMed PubMed Citation Articles by Blanco, P. G. Articles by Freedman, S. D.

LIVER AND BILIARY TRACT

Induction of colitis in cftr^–/– mice results in bile duct injury

Departments of ¹Medicine and ³Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston 02215; and ²Department of Pathology, University of Massachusetts Memorial Health Care, Worcester, Massachusetts 01655

Submitted 21 October 2003 ; accepted in final form 15 January 2004

It is unknown why some patients with inflammatory bowel disease develop primary sclerosing cholangitis. We have recently shown that patients with primary sclerosing cholangitis have an increased prevalence of mutations in the gene responsible for cystic fibrosis (CFTR) compared with individuals with inflammatory bowel disease alone. Our aim was to examine whether induction of colitis by oral dextran leads to bile duct injury in mice heterozygous or homozygous for mutations in CFTR. The effect of oral administration of docosahexaenoic acid to correct a fatty acid imbalance associated with cystic fibrosis was also examined to determine whether this would prevent bile duct inflammation. Wild-type mice and mice heterozygous and homozygous for CFTR mutations were given dextran orally for 14 days to induce colitis. Bile duct injury was quantitated by blinded histological scoring and measurement of serum alkaline phosphatase activity. The effect of pretreatment with docosahexaenoic acid for 7 days was examined. Treatment of mice with 100 mg dextran/day for 9 days followed by 85 mg/day for 5 days resulted in a significant increase in bile duct injury as determined by histological scoring in homozygous cystic fibrosis mice compared with wild-type mice (P = 0.005). The bile duct injury seen in cystic fibrosis mice was reflected in a threefold increase in serum alkaline phosphatase (P = 0.0006). Pretreatment with oral docosahexaenoic acid decreased both histological evidence of bile duct injury and serum alkaline phosphatase levels. In the setting of colitis, loss of CFTR function leads to bile duct injury.

cystic fibrosis transmembrane conductance regulator; primary sclerosing cholangitis

This article has been cited by other articles:

				S. Beharry, C. Ackerley, M. Corey, G. Kent, Y.-M. Heng, H. Christensen, C. Luk, R. K. Yantiss, I. A. Nasser, M. Zaman, et al. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G839 - G848. [Abstract] [Full Text] [PDF]